أفضل المعالجة بالدم السري أطباء الأطفال - توب -20 أطباء

يلبي المحتوى سياسة التحرير Bookimed ويتم مراجعتها طبياً من قبل

فهد مولود - طبيب عام. حاصل على 4 جوائز علمية. خدم في غرب آسيا. رئيس الفريق الطبي الناطق بالعربية سابقا ومسؤول عن معالجة البيانات ودقة المحتوى الطبي حاليا.

Nail Paksoy

أخصائي الأورام / أخصائي الثدي

13سنة خبره ١٦ سنة

5.0

2 تقييم

تركيا, إسطنبول

Medipol Bahçelievler Hospital

Nail Paksoy

أخصائي الأورام / أخصائي الثدي

13سنة خبره ١٦ سنة

الاعتمادات:

ESMO Board Certification in Medical Oncology

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Role: Subinvestigator

2. PFİZER

Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
Role: Subinvestigator

3. RECITE - AMGEN

Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
Role: Subinvestigator

4. NAVIGATE - BAYER

Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Role: Subinvestigator

5. RUBY - Tesaro (PRA)

Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
Role: Subinvestigator

7. ASTRA ZENECA

Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Role: Subinvestigator

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

Authors: Paksoy, Nail, et al.
Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

Authors: HAS SIMSEK, Duygu, et al.
Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

Authors: TURAL, Deniz, et al.
Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

Authors: FERHATOGLU, Ferhat, et al.
Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

Authors: TURAL, Deniz, et al.
Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

Authors: GÜRBÜZ, Mustafa, et al.
Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

Authors: AY, Seval, et al.
Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

Authors: CIL, Ibrahim, et al.
Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

Authors: HIZAL, Mutlu, et al.
Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

Authors: DEMIR, Semra, et al.
Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

Authors: ÖZDEMIR, Seçil Kepil, et al.
Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

Authors: Dogan, I., Paksoy, N., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

Authors: Dogan, I., Paksoy, N., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

اقرأ المزيد

5.0

2 تقييم

تكلفة استشارة الطبيب	السعر عند الطلب
المعالجة بالدم السري	$7000 - $9000

المزيد من الطرق العلاجية

احصل على استشارة مجانية معلومات

Sevil Bilir

طبيب أطفال

18سنة خبره ١٦ سنة

5.0

2 تقييم

تركيا, إسطنبول

Medipol Acibadem District Hospital

Sevil Bilir

طبيب أطفال

18سنة خبره ١٦ سنة

Education

2000, (Undergraduate / Graduate) Cerrahpaşa Faculty of Medicine, Istanbul University
2006, (PhD/ Specialty) Pediatrics, Istanbul Haydarpaşa Numune Training and Research Hospital

Experience

2001-2002, (Research Assistant) Istanbul Taksim First Aid Training and Research Hospital, Biochemistry Department
2002-2006, (Research Assistant) Istanbul Haydarpaşa Numune Training and Research Hospital
2006-2010, (Specialist) Bolu Izzet Baysal Women's Health and Pediatric Hospital
2010-2016, (Assistant Professor) Department of Pediatrics, Abant Izzet Baysal University Faculty of Medicine
2016, (Associate Professor) Department of Pediatrics, Abant Izzet Baysal University Faculty of Medicine
2018-2019, (Associate Professor) Istanbul Private Ersoy Hospital

2019-2024

(Associate Professor)

Istanbul Private Hisar Intercontinental Hospital

اقرأ المزيد

5.0

2 تقييم

احصل على استشارة مجانية معلومات

Husrev Diktas

اختصاصي مناعة

13سنة خبره ١٦ سنة

5.0

2 تقييم

تركيا, إسطنبول

Medipol Acibadem District Hospital

Husrev Diktas

اختصاصي مناعة

13سنة خبره ١٦ سنة

Education

GATA Haydarpaşa Training and Research Hospital Istanbul, Turkey

Residency program Sep 2011

Infectious Diseases and Clinical Microbiology Department fellowship program.

Gülhane Military Medical Academy Ankara, Turkey

Bachelor of Science: Medical School Aug 2003

Kuleli Military High School Istanbul, Turkey

High School Diploma Jul 1997

Experience

Health Sciences University Istanbul, Turkey

Associated Professor of Infectious Diseases Aug 2021 - Current

Associated Professor

Sisli Hamidiye Etfal Training and Research Hospital Istanbul, Turkey

Infectious Diseases Physician July 2020–August 2021

Infectious Diseases Physician

Yale School of Medicine Infectious Diseases Department New Haven, CT, USA

Associate Research Scientist June 2019- June2020

Research to improve vaccine against Tick Borne Diseases (Lyme Diseases, Babesiosis etc.)

Yale School of Medicine Infectious Diseases Department New Haven, CT, USA

Visiting Research Scientist Jul 2018 - June2019

Research to improve vaccine against Tick Borne Diseases (Lyme Diseases, Babesiosis etc.)

Turkish Ministry of Health Ankara, Turkey

Head of Health Tourism unit Feb 2017 - June 2018

Improving the health tourism policy of Turkey.

Sisli Hamidiye Etfal Training and Research Hospital Istanbul, Turkey

Infectious Diseases Physician Aug 2016 - June 2018

Infectious Diseases Physician

Tatvan Military Hospital Bitlis , Turkey

Infectious Diseases Physician Jul 2013 - Aug 2016

Infectious Diseases physician

Girne Military Hospital Turkish Republic of Northern Cyprus

Infectious Diseases Physician Oct 2011 - Jun 2013

Infectious diseases physician

GATA Training and Research Hospital Istanbul, Turkey

Residency period Jul 2006 - Sep 2011

4 th. Mechanized Infantry Brigade Command Edirne, Kesan, Turkey

Medical Doctor, May 2004 - Jun 2006

Maintaining the basic health services of the military unit.

اقرأ المزيد

5.0

2 تقييم

احصل على استشارة مجانية معلومات

Edryn Kamarul Zaman

طبيب عام

16سنة خبره ١٦ سنة

Edryn Kamarul Zaman

طبيب عام

16سنة خبره ١٦ سنة

ماليزيا, Ampang Jaya

Klinik De Palma

احصل على استشارة مجانية معلومات

اختيار الطبيب الأيمن والعيادة الطبية: نصائح الإدراك

عند تحديد الطبيب أو العيادة الطبية، ضع هذه النقاط الرئيسية في الاعتبار:

التحقق من أوراق الاعتماد

التحقق من الشهادات من هيئات مثل ISAPS، JCI، إلخ.

استعراض معدلات النجاح

اختر أطباء لديهم خبرة قوية في علاجك المحدد.

آراء المرضى

مراجعات Bookimed من مرضى حقيقيين لتصفح تجربتهم.

ضمان التواصل

اختيار العيادات التي تقدم الدعم اللغوي للعلاج السلس.

اسأل عن الخدمات

تأكد مما إذا كانوا يوفرون الإقامة والانتقالات، وتحقق من التكاليف.

قد يكون اختيار العيادة في الخارج أمرًا مرهقًا. في Bookimed، حيث ساعدنا أكثر من 800 ألف مريض، نحن نتفهم مخاوفك. نعرف كيفية العثور على الأطباء الموثوقين، وأفضل خيارات الجودة والسعر، وحلول حتى للحالات المعقدة. نحن هنا لإرشادك في كل خطوة على الطريق.

Yan Matsiivskiy

رئيس فريق المنسق الطبي

Mohd Nasir Bin Othman

اخصائي جلدية

26سنة خبره ١٦ سنة

ماليزيا, Ampang Jaya

Klinik De Palma

Mohd Nasir Bin Othman

اخصائي جلدية

26سنة خبره ١٦ سنة

الدكتور محمد ناصر بن عثمان متخصص في مجموعة متنوعة من العمليات التجميلية، بما في ذلك تجميل الأنف وشد الثدي وحقن البوتوكس والعلاج بالبوتوكس والعلاج بالخلايا الجذعية وعلاج تساقط الشعر بالبلازما الغنية بالصفائح الدموية PRP وتقشير البشرة بالليزر.اقرأ المزيد

احصل على استشارة مجانية معلومات

Carlos Rojas

جراح اختصاصي تجميل

24سنة خبره ١٦ سنة

كولومبيا, كالي

Kyron Stem Cells

Carlos Rojas

جراح اختصاصي تجميل

24سنة خبره ١٦ سنة

الدكتور كارلوس روخاس هو طبيب أمراض نساء وجراح تجميل معتمد يتمتع بخبرة تزيد عن 20 عاماً. وهو بارع في الجراحة طفيفة التوغل والجراحة بمساعدة الروبوت والجراحة التجميلية والطب التجديدي. وقد أجرى أكثر من 5,000 جراحة تجميلية، وهو متخصص في كل من العمليات الجراحية وغير الجراحية. وهو مرتبط بالجمعية الكولومبية للخلايا الجذعية في كولومبيا وحاصل على شهادات من الجمعية الكولومبية للعلاج بالأوزون.اقرأ المزيد

احصل على استشارة مجانية معلومات

Dr Serina Abdul Latif

اخصائي جلدية

20سنة خبره ١٦ سنة

Dr Serina Abdul Latif

اخصائي جلدية

20سنة خبره ١٦ سنة

ماليزيا, كوالالمبور

Merkel Clinic

احصل على استشارة مجانية معلومات

Morales

أخصائي الطب التجديدي

14سنة خبره ١٦ سنة

المكسيك, تيخوانا

BELLEZZASURGERY